Trend

Last Previous Currency Date Chng
29.42 29.69 EUR 26/04/02 -0.91

Terms

Isin LU2441282626
Contract Type N.D.
Currency EUR
Class N.Ap.
Risk Class 5
Assogestioni Category Azionari Salute
Declared Benchmark 100% Nasdaq Biotech
Start Date 22/03/08
Advisor Name N.Av.
Fund Asset Under Management 95,7367  at 25/12/31

Performance

Cumulatives
1 month +1.03
Ytd +2.26
1 year +58.86
3 years +82.62
5 years N.Av.
Yearly
02/28/2025 +32.95
02/29/2024 +13.24
02/28/2023 +17.10
02/28/2022 N.Av.
02/28/2021 N.Av.
Rating
Score
99.0291

Company

Janus Hend. Inv.Europe Sa
78, Avenue de la Libert� L-1930 - Luxembourg
Tel. N.Av.

Costs

Entrance (ACP) Min: N.Av. - Max: N.Av.
Management 0
Reimbursement N.Av.
Administrative N.Av.
Switch N.Av.
Tunnel N.D.

Subscription

One Solution
Initial N.Av. EUR
Integrative N.Av. EUR
Accumulation Plan
Duration N.Av.
Minimum Payment Unit N.Av.
Initial Payment N.Av.

Costs

Entrance (ACP) Min: N.Av. - Max: N.Av.
Management 0
Reimbursement N.Av.
Administrative N.Av.
Switch N.Av.
Tunnel N.D.

Performance

Cumulatives
1 day -0.91
1 week +2.72
1 month +1.03
3 months +1.87
6 months +31.28
From the beginning of the year +2.26
1 year +58.86
2 years +41.99
3 years +82.62
4 years +116.48
5 years N.Av.
Yearly
02/28/2025 +32.95
02/29/2024 +13.24
02/28/2023 +17.10
02/28/2022 N.Av.
02/28/2021 N.Av.


Rating
Rating Rating Rating Rating Rating
Score
99.0291

Efficiency Indicators

Sharpe 1 year 0.8598
Benchmark 1 year N.Av.
Sharpe 3 years 0.8169
Benchmark 3 years N.Av.
Sharpe 5 years N.Av.
Benchmark 5 years N.Av.
Sortino 1 year 1.9152
Benchmark 1 year N.Av.
Sortino 3 years 1.438
Benchmark 3 years N.Av.
Sortino 5 years N.Av.
Benchmark 5 years N.Av.

Absolute

Standard Volatility
1 year +28.44
3 years +22.00
5 years N.Av.
Negative Volatility
1 year +12.80
3 years +12.50
5 years N.Av.

Benchmark

Standard Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Negative Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Updated Monthly - 26/02/27

Relative

Sharpe 0.8169
Sortino 1.438
Bull Market +9.76
Bear Market -0.68
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Three years data
Risk Class 5

General

  1 year 18,005 3 years 15,888 5 years 14,134
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 18,005
882
  
+36.74
3 years 15,888
669
  
+79.77
5 years 14,134
-1
  
N.Av.
Performance
882 +36.74 669 +79.77 -1 N.Av.
Total Volatility
1 year 18,005
22,124
  
+28.44
3 years 15,888
19,135
  
+22.00
5 years 14,134
-1
  
N.Av.
Total Volatility
22,124 +28.44 19,135 +22.00 -1 N.Av.
Negative Volatility
1 year 18,005
20,676
  
+12.80
3 years 15,888
18,919
  
+12.50
5 years 14,134
-1
  
N.Av.
Negative Volatility
20,676 +12.80 18,919 +12.50 -1 N.Av.
Sharpe Index
1 year 18,005
7,718
  
+0.86
3 years 15,888
4,640
  
+0.82
5 years 14,134
-1
  
N.Av.
Sharpe Index
7,718 +0.86 4,640 +0.82 -1 N.Av.
Sortino Index
1 year 18,005
5,874
  
+1.92
3 years 15,888
4,566
  
+1.44
5 years 14,134
-1
  
N.Av.
Sortino Index
5,874 +1.92 4,566 +1.44 -1 N.Av.

By Category

  1 year 18,005 3 years 15,888 5 years 14,134
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 18,005
5
  
+36.74
3 years 15,888
3
  
+79.77
5 years 14,134
-1
  
N.Av.
Performance
5 +36.74 3 +79.77 -1 N.Av.
Total Volatility
1 year 18,005
118
  
+28.44
3 years 15,888
101
  
+22.00
5 years 14,134
-1
  
N.Av.
Total Volatility
118 +28.44 101 +22.00 -1 N.Av.
Negative Volatility
1 year 18,005
71
  
+12.80
3 years 15,888
94
  
+12.50
5 years 14,134
-1
  
N.Av.
Negative Volatility
71 +12.80 94 +12.50 -1 N.Av.
Sharpe Index
1 year 18,005
12
  
+0.86
3 years 15,888
3
  
+0.82
5 years 14,134
-1
  
N.Av.
Sharpe Index
12 +0.86 3 +0.82 -1 N.Av.
Sortino Index
1 year 18,005
11
  
+1.92
3 years 15,888
4
  
+1.44
5 years 14,134
-1
  
N.Av.
Sortino Index
11 +1.92 4 +1.44 -1 N.Av.

Foreign Funds - Janus Hend. Hor. Biotechnology Iu2 Eur: Performance, Terms, Fees, Risk, Rating


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.